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Abstract: Understanding the mechanisms of hunger, satiety and how nutrients affect appetite 
control is important for successful weight management across the lifecourse. The primary aim of 
this study was to describe acute appetite control across the lifecourse, comparing age groups 
(children, adolescents, adults, elderly), weight categories, genders and European sites (Scotland and 
Greece). Participants (n = 391) consumed four test drinks, varying in composition (15% (normal 
protein, NP) and 30% (high protein, HP) of energy from protein) and quantity (based on 100% basal 
metabolic rate (BMR) and 140% BMR), on four separate days in a double-blind randomized 
controlled study. Ad libitum energy intake (EI), subjective appetite and biomarkers of appetite and 
metabolism (adults and elderly only) were measured. The adults’ appetite was significantly greater 
than that of the elderly across all drink types (p < 0.004) and in response to drink quantities (p < 
0.001). There were no significant differences in EI between age groups, weight categories, genders 
or sites. Concentrations of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) were significantly 
greater in the elderly than the adults (p < 0.001). Ghrelin and fasting leptin concentrations differed 
significantly between weight categories, genders and sites (p < 0.05), while GLP-1 and PYY 
concentrations differed significantly between genders only (p < 0.05). Compared to NP drinks, HP 
drinks significantly increased postprandial GLP-1 and PYY (p < 0.001). Advanced age was 
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concomitant with reduced appetite and elevated anorectic hormone release, which may contribute 
to the development of malnutrition. In addition, appetite hormone concentrations differed between 
weight categories, genders and geographical locations. 
Keywords: appetite; lifecourse; gut hormones; hunger; protein 
 
1. Introduction 
Nutrition-related noncommunicable diseases are associated with increased morbidity and 
mortality at all stages of life [1,2]. Physiological and psychological responses to food change as we 
age, with impact on food choices and preferences, but little is known about how appetite control 
varies across the lifecourse [3]. This is a critical issue in combatting food intake-related chronic 
disease, commonly driven by over-consumption, but also in consideration of relative under-nutrition 
in the elderly and the clinically compromised. 
Food intake and appetite are governed across the lifecourse by complex interactions between 
peripherally synthesized gut hormones and their central receptors [4]. These interactions are subject 
to external influences, including hedonic cues and the environment [5]. Short-acting gastrointestinal 
signals include the anorexigenic peptides glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) and 
the orexigenic hormone ghrelin, while leptin maintains long-term energy homeostasis [6]. 
Homeostatic systems can, however, be overridden by hedonic signals, resulting in appetite control 
dysfunction, excess energy consumption and obesity [7]. There may be key periods in the lifecourse 
when appetite can be modulated for optimal health. For example, the onset of overweight and obesity 
starts as early as childhood and can track into adulthood [8]. Environmental factors contribute 
towards weight gain, if rewarding energy-dense foods are freely available and integrated into local 
culture, creating an obesogenic environment [9]. With advancing age, food reward signals are altered 
[10,11], food craving behavior declines, particularly in females [12] and food intake is suppressed 
[13,14], all contributing to a condition termed the “anorexia of ageing” [15]. Cross-sectional research 
reports a peak in calorie intake during late adolescence, followed by a decline, with calorie intake 
reducing by 1300 kcal/day on average between 20 and 80 years of age for males and 600 kcal/day for 
females [16]. Understanding how dietary interventions influence physiological and behavioral 
mediators of appetite at different stages of life is vital for effective long-term weight control [17]. 
High-protein diets are often recommended for weight management, as they are highly satiating [18–
20], and in the prevention and treatment of malnutrition, particularly in elderly populations [21]. 
Protein-induced satiety has been observed acutely, within single meals that contained 25% to 81% of 
energy from protein, associated with reductions in subsequent energy intake (EI) compared to lower 
protein alternatives [22]. In children and adolescents, studies have reported either an appetite 
suppressant effect of increased protein content [23] or no effect [24]. In addition, breakfasts high in 
protein have been shown to induce greater hunger suppression compared to breakfasts with a lower 
protein content in adults [25]. It is not well understood how interactions between protein and appetite 
control differ between children, adolescents, adults and the elderly since studies are rarely conducted 
across the lifecourse. 
The primary aim of this study was to describe the acute regulation of appetite across the 
lifecourse, thus being able to detect differences between four different age groups (children, 
adolescents, adults and elderly), two different weight categories (normal weight and overweight), 
the two genders (male and female) and two European sites (Aberdeen, Scotland and Athens, Greece). 
The secondary aim was to examine the short-term effects of breakfast test drinks varying in protein 
composition and quantity on appetite control. Our study is unique in that it applies an individualized 
appetite challenge across the lifecourse in lean and overweight males and females in northern and 
southern Europe. 
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2. Materials and Methods 
2.1. Participants 
Normal weight and overweight/obese and male and female child, adolescent, adult and elderly 
participants (age range 7–77 years) were recruited in Scotland and Greece as part of an identical, dual-
site within-day dietary intervention study, thereby creating four groups: age (children, adolescents, 
adults and elderly), weight category (normal weight and overweight), gender (male and female) and 
site (Scotland and Greece). Recruitment of volunteers was by public advertisement using radio, 
newspapers and social media, and was conducted from May 2012 to August 2015. When requested, 
study information sessions were conducted at schools, health care centers and day care centers for 
the elderly. Participants were individuals who were motivated to actively respond to the volunteer 
request. Exclusion criteria included: smokers; morbid obesity (BMI ≥ 40 kg/m2); pregnancy; obesity 
of known endocrine origin; neurological disorders; medication known to influence appetite 
(including orlistat, oral antidiabetics, insulin, digoxin, anti-arrhythmics, sibutramine, 
antidepressants); self-reported fever/systemic infection; participation in medical or surgical weight 
loss program within 1 month of selection; history of cerebrovascular disease; current major 
depressive disorder; history of cardiovascular disease; chronic obstructive pulmonary disease; an 
allergy to any of the test drink components and partaking in > 6 h of vigorous physical activity per 
week. This study was conducted according to the guidelines laid down in the Declaration of Helsinki 
[26]. Ethical approval in Aberdeen was granted by the National Health Service North of Scotland 
Research Ethics Service. Ethical approval in Athens was granted by the Bioethics Committee of 
Harokopio University and the Greek Ministry of Education for the implementation of the study in 
schools. The study received ethical approval from NHS Grampian, Aberdeen, Scotland, UK and the 
Research Ethics Committee (reference number: 12/NS/0007). All participants provided written 
informed consent before entering the study and, in addition, the parents/guardians of the children 
consented for their child to participate. 
2.2. Experimental Procedures and Protocol 
Data on children and adolescents were collected at schools and adults and elderly attended the 
Rowett Institute, University of Aberdeen, Scotland (ABDN) and the Department of Nutrition-
Dietetics, Harokopio University Athens, Greece (HUA). Prior to the main experimental trials, 
preliminary anthropometric measures were carried out under standardized conditions. During the 
main experimental trials, participants consumed four test drinks for breakfast on four separate 
occasions using a double-blind randomized controlled crossover design, with at least a 4 day period 
between trials. On the morning of each trial, participants arrived following an overnight fast (10 h) 
and having refrained from alcohol consumption and strenuous exercise for 12 h. Test drinks were 
consumed immediately following baseline measures (0 min), then at 120 min post-baseline, ad 
libitum EI was measured by means of a 30 min buffet-style test meal, after which participants were 
free to leave. Subjective appetite sensations were assessed using visual analog scales (VASs) at 0, 30, 
60, 90 and 120 min (pre-meal), pleasantness and satisfaction VASs were also completed immediately 
post-test drink. Blood samples were taken at 0, 30, 60 and 120 min to determine biomarker 
concentrations. The true aims of the study were concealed from the participants; however, all 
participants were fully debriefed following their completion of the study. See Figure 1 for an 
overview of the experimental protocol. This trial was registered at clinicaltrials.gov as NCT01597024. 
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Figure 1. Experimental design (A) and test day protocol (B). anthropometric measurements,  
LFPQ,  appetite ratings (Likert scale, children and adolescents; VAS, adult and elderly),  
blood sampling (adult and elderly cohorts only), randomized test drink intake (NPMT, NPWL, 
HPMT or HPWL),  ad libitum food intake from buffet-style test meal; (HPMT) high-protein 
maintenance, HPWL: high-protein weight loss, LFPQ: Leeds Food Preference Questionnaire, NPMT: 
normal-protein maintenance, NPWL: normal-protein weight loss, VAS: visual analog scale. 
2.3. Anthropometric Measures 
Height, body mass, waist circumference and body composition were measured in the fasted 
state and after voiding as described previously [27]. Height was measured to the nearest 0.1 cm using 
a portable stadiometer (Model 213, SECA, Hamburg, Germany). Body mass, measured to the nearest 
0.1 kg, and body composition were assessed using a multi frequency segmental body composition 
analyzer (Model BC-418-MA, Tanita Corporation, Tokyo, Japan). Body mass index was calculated for 
each participant and compared against the age- and gender-matched thresholds for normal weight 
and overweight, as defined by the World Health Organization [28]. In addition, waist circumference 
and visceral fat percentage measures were performed using abdominal bioelectrical impedance 
analysis (AB 140 Viscan, Tanita Corporation, Tokyo, Japan), with participants in the supine position. 
2.4. Test Drinks 
The test drinks provided for the study were designed by Nutricia (Danone, Utrecht, 
Netherlands) to taste, look and smell identical. One test drink was created with a normal-protein (NP) 
composition (15% energy from protein) and the other was created with a high-protein (HP) 
composition (30% energy from protein). The test drink compositions are presented in Table 1 and 
compared with whole milk. The test drink quantity either corresponded to 100% of the participant’s 
estimated basal metabolic rate (BMR, kcal/day; weight loss requirements, WL) or 140% of the 
participant’s estimated BMR (weight maintenance requirements, MT). Basal metabolic rate was 
estimated for all age groups according to equations derived by Schofield [29], suitable for children 
and adults (see Table S1 for the equations used to estimate BMR). When calculating participant 
energy requirements for the MT drinks, BMR was multiplied by a correction factor of 1.4, whereas 
when calculating energy requirements for the WL drinks, BMR was multiplied by a correction factor 
of 1. In addition, for the purposes of this study, breakfast was defined as the first meal of the day 
consisting of 25% of the participant’s daily energy requirements, which is similar to previous studies 
[30,31]. Therefore, when calculating participant energy requirements for both drinks, daily BMR was 
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multiplied by 0.25. The following formulas give the energy requirements (ER) for the MT and WL 
test drinks, respectively: 
ERMT = BMR × 1.4 × 0.25 (1) 
ERWL = BMR × 1 × 0.25 (2) 
Table 1. Composition of the high-protein and normal-protein test drinks per 100mL compared to 
whole milk. 
Product (per 100mL) HP Drink NP Drink Whole Milk 
Total energy (kcal) 130 130 63 
Protein 
(g) 10.0 5.0 3.4 
Energy (%) 30.7 15.3 21.9 
Casein (g) 8.0 4.0 2.7 
Whey (g) 2.0 1.0 0.7 
Fat 
(g) 3.5 3.5 3.6 
Energy (%) 24.2 24.2 50.6 
Carbohydrate 
(g) 14.7 19.7 4.6 
Energy (%) 45.1 60.5 27.9 
Lactose (g) <0.06 <0.06 4.6 
HP: high-protein test drink, NP: normal-protein test drink. 
The quantity of each drink to be served was calculated considering the energy density of the 
drinks. The energy density of the drinks in kcal/100mL (EDkcal/100mL) was:  
EDkcal/100mL = 130 kcal/100 mL (3) 
The physical density (d) of the drinks was 1.088 kg/L. Therefore, the energy density of the drinks 
in kcal/100g (EDkcal/100g) was:  
EDkcal/100 g = (EDkcal/100 mL ÷ d × 100) × 100 (4) 
EDkcal/100 g = 130 ÷ 1.09 = 119 kcal/100 g (5) 
 
Finally, the quantity of drink to be served was as follows:  
Quantity (g) = (ER ÷ EDkcal/100 g) × 100 = (ER ÷ 119) × 100 (6) 
Each participant consumed the four different types of test drink: normal-protein weight loss 
(NPWL), normal-protein weight maintenance (NPMT), high-protein weight loss (HPWL) and high-
protein weight maintenance (HPMT) in a randomized order and at a standardized time. The 
composition of the test drinks was double-blinded and the drinks were labeled A, B, C and D. 
Nutricia labeled the drinks and generated the random allocation sequence. The drinks were weighed 
to the nearest gram and placed into neutral sealed cups with a straw. Participants were required to 
consume at least 80% of each drink and failure to do so would result in their withdrawal from the 
study. The composition of the drinks was unblinded to the researchers after the final participant 
completed the study. 
2.5. Ad Libitum EI 
The ad libitum buffet-style test meal consisted of a counter-balanced selection of 25 sweet and 
savory, high- and low-calorie food and drink items, all of which were provided in excess (Table S2). 
All food and drink items were chosen to be commercially available in the UK and Greece. Buffet items 
were offered either in transparent plastic containers or in their original packaging. The buffet was 
provided 120 min after test drink consumption, participants were given access to the buffet for 30 
min and instructed to consume as much or as little of each buffet item as they wanted until they were 
satisfied. All foods and drinks were presented identically on each occasion and covertly weighed 
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before and after the buffet. Ad libitum energy and macronutrient intakes were calculated using 
nutritional values provided by the manufacturer, or by using an electronic version of McCance and 
Widdowson’s The Composition of Foods [32]; NETWISP™ software (version 3.0 for Windows, 
Tinuviel Software, Anglesey, UK). 
2.6. Subjective Appetite Assessment 
Appetite perceptions (hunger, fullness and prospective food consumption (PFC)) were 
measured in adult and elderly participants using previously validated 100mm visual analog scales 
(VASs, [33]). Participants indicated their subjective feelings of appetite by marking a vertical line on 
the VAS. A composite appetite score was calculated at each time of measurement using the following 
formula:  
[Hunger + (100 − fullness) + prospective consumption]/3 (7) 
Higher composite appetite scores relate to elevated feelings of appetite. The composite appetite 
score is increasingly used in the literature for ease of data analysis and presentation [25,34]. 
Children and adolescents used a 9-point Likert scale to rate fullness (How full do you feel?) and 
PFC (How much do you think you could eat now?), with 1 representing “Not at all full”/”Nothing at 
all” and 9 representing “As full as I’ve ever felt”/”A large amount” for fullness and PFC, respectively. 
Participants were not permitted to view their previous ratings when completing the scales. 
2.7. Test Drink Pleasantness and Satisfaction 
After consuming the test drinks, participants rated the drinks for pleasantness and satisfaction. 
The adult and elderly participants used a 100 mm VAS to rate the drinks, with “Not at all 
pleasant”/”Not at all satisfying” on the left side and “Extremely pleasant”/”Very satisfying” on the 
right side of the pleasantness and satisfaction scales. Children and adolescents used a 9-point Likert 
scale adapted from Jansen et al. [35] to rate the drinks for pleasantness and satisfaction. The scale 
consisted of 5 cartoon faces (smileys). The first cartoon face on the left (unhappy) reflecting low 
perceived pleasantness/satisfaction was scored 1 and the last face (very happy) on the right of the 
scale, reflecting high perceived pleasantness/satisfaction, was scored 9. Participants could rate in 
between two faces, creating a 9-point scale. 
2.8. Food Reward: Leeds Food Preference Questionnaire (LFPQ) 
The Leeds Food Preference Questionnaire [36] provided a baseline measure of liking and 
wanting along dimensions of fat and taste. Participants were presented with an array of pictures of 
individual food items common in the diet. Foods were chosen by the local research team from a 
validated database to be either predominantly high (>50% energy) or low (<20% energy) in fat, sweet 
or savory in taste, but similar in familiarity, protein content and cultural suitability for the study 
population [37]. The LFPQ has been validated in previous studies investigating dietary protein [38–
40]. Explicit liking was measured by participants rating the extent to which they liked each food using 
a 100 mm VAS (“How pleasant would it be to taste this food now?”). Implicit wanting was assessed 
using a forced choice methodology so that every image from each of the four food types was 
compared to every other type over 96 trials (food pairs). Reaction times for all responses were covertly 
recorded for each food type after adjusting for frequency of selection [37]. Fat bias scores for liking 
and wanting were calculated as the difference between the high-fat scores and the low-fat scores. 
Sweet bias scores were calculated as the difference between the sweet and savory scores. Positive 
values indicated greater liking/wanting for high fat > low fat or sweet > savory and negative values 
indicated the reverse.  
2.9. Blood Sampling and Processing 
At all test visits, glucose, insulin, total ghrelin, PYY and GLP-1 were measured fasted and 
postprandially (at 30, 60 and 120 min after eating), while leptin was measured at the first test visit 
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only. An intravenous cannula (BD Venflon, BD, UK) was inserted into an antecubital vein for the 
collection of venous blood samples. During the trials, the cannula was kept patent with 2mL flushes 
of 0.9% NaCl(aq) isotonic saline solution (Baxter Healthcare, UK) after each bloodletting. At each 
time point, a venous blood sample was collected into a 4.9mL EDTA-coated monovette (S-Monovette, 
Sarstedt, Nümbrecht, Germany) for the measurement of plasma total ghrelin, PYY and GLP-1 
concentrations. A second venous blood sample was collected into a 2.7 mL lithium heparin-coated 
monovette (S-Monovette, Sarstedt, Nümbrecht, Germany) for the measurement in plasma of leptin, 
glucose and insulin. Immediately after blood collection, collection tubes were placed in ice and 160µL 
of a preservative containing 4-(2-aminoethyl) benzenesulfonylfluoride hydrochloride (Roche, Basel, 
Switzerland), dipeptidyl peptidase-4 inhibitor (Merck Millipore, Darmstadt, Germany) and protease 
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) were added to EDTA-coated monovettes. 
After gentle inversion, both monovettes were spun at 1000g for 15 min in a centrifuge at 4 °C and 
plasma was stored at −80 °C for batch analysis at the conclusion of the study. Identical blood sampling 
and processing procedures were followed at ABDN and HUA. Blood samples were collected from 
adult and elderly participants only. No samples were collected from children, as gaining ethical 
approval for blood samples in this vulnerable group was challenging. 
2.10. Biomarker Analysis 
2.10.1. Appetite Hormones 
Total ghrelin concentrations were measured using a human-specific radioimmunoassay kit 
(Linco Research, St. Charles, MO, USA) at the laboratory of JJ Holst. The lowest concentration of 
ghrelin detectable using this assay was 93 pg/mL. The limit of linearity for this assay was 6000 pg/mL. 
All samples were read using a gamma counter. The between- and within-volunteer CVs were 39% 
and 14%, respectively. Total PYY and GLP-1 were measured in duplicate using an electrochemical 
luminescence immunoassay kit (Meso Scale Discovery, Rockville, Maryland, USA) on the Meso Scale 
Discovery® multiarray assay platform (Meso Scale Discovery, Rockville, Maryland, USA) at the Core 
Biomedical Assay Laboratory (CBAL), Cambridge. The PYY immunoassay measured both PYY1–36 
and PYY3–36 with a range of 30-3000 pg/mL. Inter-assay CVs of 7.8–16.4% were obtained. The GLP-1 
immunoassay measures all endogenous forms of GLP-1 (including GLP-11-36, GLP-11-37, GLP-17-
36, GLP-17-37, GLP-19-36 and GLP-19-37) and has a range of 1.4-1000 pg/mL and CVs of 5.2–8.2% for 
most of the analytical range. Leptin analysis was performed at CBAL using an in-house two-site 
DELFIA® assay, which used a monoclonal capture antibody and a polyclonal detection antibody with 
fluorescent detection using europium-labeled streptavidin [41,42]. The antibodies and standards 
were sourced from R&D Systems (R&D Systems Europe, Abingdon, UK). This assay had a lower 
limit of detection of 0.1 ng/mL and intra-assay CVs of 3.9–7.1%. 
2.10.2. Glucose Homeostasis 
Glucose and insulin plasma analysis was conducted at the University of Aberdeen, Rowett 
Institute, Technical Services department. Glucose concentrations were measured using a hexokinase 
method on a Dimension® clinical chemistry analyzer (Siemens Healthcare GmbH, Erlangen, 
Germany) with CVs of <2% within the reference range. Insulin was detected using a Liaison® XL 
automated immunoassay analyzer (DiaSorin, Italy) with a chemiluminescence immunoassay, which 
had a range of 20-3470 pmol/L and intra-assay CVs of 5.0–6.0% across the analytical range. The 
homeostatic model assessment [43] was used to estimate hepatic insulin resistance (HOMA-IR): 
IRinsulin: fasting glucose (mmol/L) × fasting insulin (mU/L)/22.5 (8) 
β-cell function was measured using an early insulin secretion function index (insulinogenic 
index (IGI)): 
IGI: (Insulin_0 min−Insulin_30 min)/(Glucose_0 min−Glucose_30 min) (9) 
Insulin to glucose ratio (IGR) was also calculated. 
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2.11. Statistical Analysis 
It was calculated that 16 participants in each group (defined by age, BMI, gender and study site) 
would give approximately 80% power to detect group and treatment differences in any variable 
comparable to the unpredictable variation between groups or within individuals, i.e., to detect a 
standard effect size of approximately 1.0. Main factor effect comparisons are based on combinations 
of groups and so larger volunteer numbers had the power to detect smaller effect sizes. 
Variables were analyzed by linear mixed models using residual maximum likelihood with 
random effect terms for volunteer and fixed effect terms for test drink type, age group, BMI group, 
gender, site and all two-way and three-way interactions. An additional analysis was carried out in 
each case in which the drink effect was decomposed into its factorial components of composition (HP 
vs. NP) and quantity (WL vs. MT). Where data were collected at several timepoints in a day (appetite 
scores and gut hormones), an additional random effect term for day, and fixed effect term for time, 
were included in the models. Significance of fixed effect terms was assessed by F statistics calculated 
from Wald statistics, with estimated denominator degrees of freedom. Drinks were compared with 
post hoc tests based on least significant differences. A p value < 0.05 was considered to indicate 
statistical significance. Analyses were carried out using Genstat v17 (VSN International, UK). Data 




In total, 424 members of the public were enrolled in the study (See the Consolidated Standards 
of Reporting Trials (CONSORT) flow diagram (Figure S1) summarizing the participant flow). Thirty-
three participants discontinued the study after randomization, of which five were excluded as they 
consumed <80% of at least one of the test drinks. Therefore, 391 participants across ABDN and HUA 
completed the study, as 103 children, 109 adolescents, 97 adults and 82 elderly. The characteristics of 
the participants from ABDN and HUA who completed the study are presented in Table 2. In addition, 
Supplementary Materials Table S3 presents the number of participants allocated to each group at 
both sites.
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Table 2. Participant characteristics by age group and site 1. 
 
Children Adolescents Adults Elderly 
ABDN (n = 
39) 
HUA (n = 
64) 
All (n = 
103) 
ABDN (n = 
45) 
HUA (n = 
64) 
All (n = 
109) 
ABDN (n = 
46) 
HUA (n = 
51) 
All (n = 
97) 
ABDN  
(n = 36) 
HUA (n = 
46) 
All (n = 
82) 
Age (years) 8.72 ± 0.69 9.20 ± 0.65 9.02 ± 0.70 15.4 ± 1.28 14.5 ± 1.33 14.9 ± 1.37 29.9 ± 7.34 32.8 ± 6.71 31.4 ± 7.13 
68.0 ± 
3.82 
68.5 ± 3.88 68.3 ± 3.84 
Height (m) 1.37 ± 0.08 1.40 ± 0.06 1.39 ± 0.07 1.65 ± 0.09 1.67 ± 0.09 1.66 ± 0.09 1.71 ± 0.09 1.71 ± 0.10 1.71 ± 0.09 
1.64 ± 
0.08 
1.62 ± 0.08 1.62 ± 0.08 
Weight (kg) 31.6 ± 6.94 38.3 ± 8.39 35.7 ± 8.49 60.3 ± 12.3 65.7 ± 10.4 63.4 ± 11.5 71.0 ± 14.2 76.1 ± 14.4 73.7 ± 14.5 
68.6 ± 
11.9 
75.7 ± 14.4 72.6 ± 13.7 
BMI (kg/m2) 16.7 ± 2.41 19.5 ± 3.33 18.4 ± 3.31 22.2 ± 4.23 23.5 ± 2.82 23.0 ± 3.51 24.3 ± 4.07 25.9 ± 4.33 25.1 ± 4.27 
25.5 ± 
3.58 
28.9 ± 4.71 27.4 ± 4.55 
BMR 2 (MJ) 4.93 ± 0.62 5.52 ± 0.82 5.30 ± 0.8 6.70 ± 1.02 7.14 ± 1.04 6.96 ± 1.05 6.67 ± 1.04 7.18 ± 1.17 6.94 ± 1.13 
5.73 ± 
0.74 
6.54 ± 1.00 6.19 ± 0.98 
Body fat 3 (%) 22.8 ± 5.70 25.4 ± 5.93 24.4 ± 5.95 24.8 ± 8.47 24.8 ± 7.54 24.8 ± 7.90 23.6 ± 10.1 26.2 ± 9.95 24.9 ± 10.1 
32.4 ± 
6.78 
35.4 ± 6.78 34.2 ± 6.90 
Waist Circumference 4 
(cm) 
64.5 ± 8.56 71.8 ± 12.4 69.6 ± 11.8 81.6 ± 10.9 84.9 ± 9.75 83.7 ± 10.3 91.4 ± 13.0 96.9 ± 12.4 94.4 ± 12.9 100 ± 14.0 109 ± 12.8 106 ± 14.0 
Visceral Fat 4 (%) 3.67 ± 2.23 4.95 ± 3.25 4.58 ± 3.03 5.43 ± 3.67 6.05 ± 3.28 5.81 ± 3.43 7.72 ± 4.92 9.64 ± 4.64 8.76 ± 4.84 
10.4 ± 
4.25 
15.1 ± 6.76 13.2 ± 6.29 
1 Values are means ± SD; 2 calculated by Schofield equation; 3 measured by whole body BIA; 4 measured by abdominal VISCAN bio-impedance; ABDN: Scotland, 
BIA: bioelectrical impedance analysis, BMR: basal metabolic rate, HUA: Greece.
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3.2. Test Drinks 
The average test drink energy (kcal) and protein (g) consumption, corrected for mass consumed, 
varied significantly between age groups (p < 0.001; Table 3). 
Table 3. Test drink energy and protein consumption 1. 











Children (n = 102) 306 425 304 425 
10 <0.001 
Adolescents (n = 
108) 
406 565 402 557 
Adults (n = 97) 399 553 395 548 







) Children (n = 102) 11.4 15.9 23.3 32.6 
0.6 <0.001 
Adolescents (n = 
108) 
15.2 21.1 30.8 42.7 
Adults (n = 97) 14.9 20.6 30.3 42.0 
Elderly (n = 82) 13.0 18.0 26.3 36.6 
1 Corrected for mass consumed. Mean data are presented for drink type (NPWL, NPMT, HPWL, 
HPMT); 2 determined by ANOVA, differences are statistically significant when p < 0.05; HPMT: high-
protein maintenance, HPWL: high-protein weight loss, NPMT: normal-protein maintenance, NPWL: 
normal-protein weight loss. 
3.3. Ad Libitum EI 
Differences in mean ad libitum EI after the test drinks between age groups, weight categories, 
genders and sites are presented in Table 4. Differences between age groups in response to the quantity 
of drink provided (WL vs. MT) approached significance (p = 0.074). 
Table 4. Ad libitum EI (kcal) 1. 




Children (n = 
103) 







(n = 109) 
950 876 940 852 914 895 945 864 
Adults (n = 
97) 
672 603 641 627 639 634 658 615 
Elderly (n = 
82) 





Weight (n = 
221) 







(n = 170) 





 Males (n = 
171) 






Females (n = 
220) 




HUA (n = 
225) 






ABDN (n = 
166) 
627 555 572 555 591 565 600 555 
1 n = 391. Mean data are presented for drink type (NPWL, NPMT, HPWL, HPMT), drink composition 
(NP, HP) and drink quantity (WL, MT); 2 determined by ANOVA (with age, BMI, gender and site as 
fixed factors), differences are statistically significant when p < 0.05; ABDN: Scotland, EI: energy intake, 
HP: high protein, HPMT: high-protein maintenance, HPWL: high-protein weight loss, HUA: Greece, 
MT: weight maintenance, NP: normal protein, NPMT: normal-protein maintenance, NPWL: normal-
protein weight loss, WL: weight loss. 
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There were no significant differences between weight categories, genders or sites. Furthermore, 
there were no significant differences in total caloric intake (test drink EI + ad libitum EI) between age 
groups, weight categories, genders or sites in response to drink type, composition or quantity (Table 
5). 
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(n = 170) 
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HUA (n = 
225) 
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1 n = 391. Mean data are presented for drink type (NPWL, NPMT, HPWL, HPMT), drink composition 
(NP, HP) and drink quantity (WL, MT); 2 determined by ANOVA (with age, BMI, gender and site as 
fixed factors), differences are statistically significant when p < 0.05; ABDN: Scotland, EI: energy intake, 
HP: high protein, HPMT: high-protein maintenance, HPWL: high-protein weight loss, HUA: Greece, 
MT: weight maintenance, NP: normal protein, NPMT: normal-protein maintenance, NPWL: normal-
protein weight loss, WL: weight loss.  
The data for mean ad libitum energy and macronutrient intake with all participants combined 
are reported in Table S4, to explore drink effects. Ad libitum EI was significantly greater after 
consuming the NPWL drink, in comparison to the other drink types (p < 0.001). There were small but 
statistically significant differences in energy and macronutrient intakes between drinks fed at WL or 
MT quantities, reflected by higher intakes after WL (all p < 0.001). There were no differences in ad 
libitum energy or nutrient intakes between the NP and HP drinks.  
Visit number had a significant effect on ad libitum EI, with EI significantly greater for visits 2, 3 
and 4 compared to visit 1 for all participants combined (Supplementary Materials Table S5; p = 0.001). 
In addition, the effect of visit number on ad libitum EI differed significantly between age groups (p < 
0.001). 
3.4. Subjective Appetite Assessment 
Table 6 presents the fullness and PFC ratings for drink type, composition and quantity x time 
interactions for children and adolescents. Fullness did not differ between children and adolescents in 
response to drink type (p = 0.252), composition (p = 0.220) or quantity (p = 0.554). There were no 
significant differences in ratings of PFC in response to drink type (p = 0.332), composition (p = 0.209) 
or quantity (p = 0.653) when comparing children and adolescents. There were no significant 
differences in fullness or PFC ratings between weight categories, genders or sites (data not shown). 
Table 7 presents the composite appetite score for drink type, composition and quantity x time 
interactions for adults and elderly. The adults’ appetite score was significantly greater than that of 
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the elderly across all drink types (p < 0.004) and in response to both drink quantities (p < 0.001). There 
were no significant differences between adult and elderly appetite scores in response to drink 
composition (p = 0.624). There were no significant differences in composite appetite scores between 
weight categories, genders or sites (data not shown). 
3.5. Test Drink Pleasantness and Satisfaction 
There was a significant difference in pleasantness ratings between drinks for the children and 
adolescents and the adults and elderly, with a significantly higher rating for the NPWL drink, in 
comparison to the NPMT, HPWL and HPMT drinks (children and adolescents (n = 212): 5.14, 4.80, 
4.97, 4.60, respectively; p < 0.001; SED: 0.12; adults and elderly (n = 179): 68.4, 64.6, 64.7, 62.5 mm, 
respectively; p = 0.002; SED: 1.9). Participants also preferred the NP over HP composition (children 
and adolescents: 4.97, 4.78, respectively; p = 0.032; SED: 0.09; adults and elderly: 66.5, 63.6 mm, 
respectively; p = 0.012; SED: 1.3) and the WL over the MT quantity (children and adolescents: 5.05, 
4.70, respectively; p < 0.001; SED: 0.09; adults and elderly: 66.5, 63.6 mm, respectively; p = 0.04; SED: 
1.3). Average pleasantness ratings were significantly higher in the ABDN children and adolescent 
cohort (n = 84) compared to the HUA cohort (n = 128; 5.86, 3.89, respectively; p < 0.001; SED: 0.22). 
Average satisfaction ratings were significantly higher in the children (n = 103) compared to the 
adolescents (n = 109; 5.17, 4.27, respectively; p = 0.009; SED: 0.20). Children and adolescent females (n 
= 107) reported significantly higher average satisfaction ratings compared to males (n = 105; 4.95, 4.49, 
respectively; p = 0.037; SED: 0.20), and average satisfaction ratings were higher in the ABDN children 
and adolescent cohort (n = 84) compared to the HUA cohort (n = 128; 5.45, 3.99, respectively; p < 0.001; 
SED: 0.20). There were no differences between age groups, weight categories, genders or sites and no 
effect of drink on satisfaction ratings in the adults and elderly (n = 179; data not shown). 
3.6. Food Reward: LFPQ 
Fat bias scores (liking and wanting scores for high-fat relative to low-fat foods) and sweet bias 
scores (scores for sweet relative to savory foods) were compared according to age, BMI, gender and 
site (Table S6). There was a main effect of age group on liking (p = 0.001) and wanting (p < 0.001) for 
high-fat food. Post hoc analyses showed that the elderly had the lowest fat preference, followed by 
adults, and that both groups showed a clear preference (liking and wanting) for low-fat relative to 
high-fat foods. Adolescents showed a greater liking and wanting for high-fat relative to low-fat food. 
There was also an effect of age group on wanting for sweet foods (p < 0.001), with a greater wanting 
for sweet in children, adolescents and elderly compared to adults (p < 0.05). For BMI, while there 
were no group differences for liking and wanting fat bias, liking (p = 0.047) and wanting (p = 0.059) 
sweet bias tended to be greater in normal weight than overweight participants. There was no main 
effect of gender. There was a main effect of site on liking and wanting for sweet (both p = 0.019) and 
high-fat (both p < 0.001) foods, with the ABDN population showing a greater sweet and fat preference 
compared to HUA.  
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Table 6. Children 1 and adolescent 2 motivation to eat at baseline and in response to test drink type, composition and quantity. 
 Time (mins) NPWL NPMT HPWL HPMT SEDtype 
Type.Time Interaction NP HP SEDcomposition Composition.Time Interaction WL MT SEDquantity Quantity.Time Interaction 




















30 3.73 3.86 3.37 3.71 3.79 3.54 3.55 3.78 
60 3.06 3.14 3.02 2.83 3.10 2.92 3.04 2.98 
90 2.60 2.75 2.52 2.51 2.68 2.51 2.56 2.63 















30 4.49 4.85 5.06 5.13 4.67 5.10 4.78 4.99 
60 4.15 4.44 4.52 4.59 4.29 4.56 4.33 4.52 
90 3.65 3.94 3.91 4.06 3.80 3.98 3.78 4.00 


















30 6.00 6.00 6.22 5.90 6.00 6.06 6.11 5.95 
60 6.70 6.55 6.54 6.96 6.62 6.75 6.62 6.76 
90 7.14 7.14 7.05 7.26 7.14 7.16 7.10 7.20 















30 5.08 4.63 4.58 4.31 4.85 4.44 4.83 4.47 
60 5.47 5.05 5.08 4.96 5.26 5.02 5.27 5.01 
90 5.85 5.66 5.61 5.61 5.76 5.61 5.73 5.64 
120 6.42 6.08 6.07 6.10 6.25 6.09 6.25 6.09 
1 n = 103 for children; 2 n = 109 for adolescents; 3 determined by ANOVA between age groups, differences are statistically significant when p < 0.05. Mean data are 
presented for drink type (NPWL, NPMT, HPWL, HPMT), drink composition (NP, HP) and drink quantity (WL, MT); HP: high protein, HPMT: high-protein 
maintenance, HPWL: high-protein weight loss, MT: weight maintenance, NP: normal protein, NPMT: normal-protein maintenance, NPWL: normal-protein weight 
loss, PFC: prospective food consumption, WL: weight loss.
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Table 7. Adult1 and elderly2 composite appetite scores at baseline and in response to test drink type, composition and quantity. 
 Time (mins) NPWL NPMT HPWL HPMT SEDtype 
Type.Time Interaction NP HP SEDcomposition Composition.Time Interaction WL MT SEDquantity Quantity.Time Interaction 























1.6 < 0.001 
30 42.6 35.5 41.2 34.8 39.0 38.0 41.9 35.1 
60 46.7 40.3 44.6 37.9 43.5 41.3 45.7 39.1 
90 52.0 44.8 49.6 42.4 48.4 46.0 50.8 43.6 












30 31.4 28.6 29.7 31.3 30.0 30.5 30.5 30.0 
60 35.2 33.7 34.7 33.0 34.4 33.9 35.0 33.3 
90 40.9 37.5 39.1 36.5 39.2 37.8 40.0 37.0 
120 44.3 41.9 43.2 38.3 43.1 40.8 43.7 40.1 
1 n = 97 for adults; 2 n = 82 for elderly; 3 determined by ANOVA between age groups, differences are statistically significant when p < 0.05. Mean data are 
presented for drink type (NPWL, NPMT, HPWL, HPMT), drink composition (NP, HP) and drink quantity (WL, MT); HP: high protein, HPMT: high-protein 
maintenance, HPWL: high-protein weight loss, MT: weight maintenance, NP: normal protein, NPMT: normal-protein maintenance, NPWL: normal-protein 
weight loss, VAS: visual analog scale, WL: weight loss.
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3.7. Biomarkers 
Note that, of the 179 adult and elderly participants, four normal weight adults and three normal 
weight elderly from ABDN were unable to provide blood samples, therefore, 172 participants were 
included in the biomarker analyses. 
3.7.1. Appetite Hormones 
Differences in GLP-1, PYY and ghrelin concentrations between age groups, weight categories, 
genders and sites in response to all test drinks combined are presented in Figures 2 (GLP-1), 3 (PYY) 
and 4 (ghrelin). GLP-1 and PYY baseline concentrations did not differ significantly between groups 
for age, BMI, gender or site comparisons. Ghrelin baseline concentrations did not differ significantly 
between age groups, but baseline differences are reported for gender, BMI and site comparisons (all 
p < 0.001). Plasma concentrations of GLP-1 (Figure 2A) and PYY (Figure 3A) were significantly greater 
in the elderly than the adults (both p < 0.001), however, there were no significant differences in ghrelin 
release between age groups (Figure 4A; p = 0.119). There were no significant differences in GLP-1 
(Figure 2B; p = 0.996) or PYY (Figure 3B; p = 0.826) responses between normal weight and overweight 
participants, however, normal weight participants exhibited significantly greater ghrelin 
concentrations when compared to overweight participants (Figure 4B; p < 0.001). Concentrations of 
all three hormones were greater in females in comparison to males (p = 0.039, p = 0.028 and p < 0.001 
for GLP-1 (Figure 2C), PYY (Figure 3C) and ghrelin (Figure 4C), respectively). There were no 
differences in GLP-1 (Figure 2D) or PYY (Figure 3D) concentrations between ABDN and HUA 
participants, though ghrelin concentrations were greater in the ABDN cohort compared to the HUA 
cohort (Figure 4D; p < 0.001). Interestingly, ghrelin differences between sites could not be explained 
by differences in body composition or gender.  
 
Figure 2. Plasma concentrations of GLP-1 in the adult and elderly cohorts in response to all test drinks 
combined. Data are presented as mean ± SED, n = 172; seven ABDN participants (four normal weight 
adults, three normal weight elderly) did not complete this measurement. Determined using an 
electrochemical luminescence immunoassay kit, values were analyzed as repeated measurements 
using ANOVA, differences are statistically significant when p < 0.05. (A) Comparison of age group, 
(B) comparison of BMI group, (C) comparison of gender, (D) comparison of site. ABDN: Scotland, 
GLP-1: glucagon-like peptide 1, HUA: Greece. 
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Figure 3. Plasma concentrations of PYY in the adult and elderly cohorts in response to all test drinks 
combined. Data are presented as mean ± SED, n = 172; seven ABDN participants (four normal weight 
adults, three normal weight elderly) did not complete this measurement. Determined using an 
electrochemical luminescence immunoassay kit, values were analyzed as repeated measurements 
using ANOVA, differences are statistically significant when p < 0.05. (A) Comparison of age group, 
(B) comparison of BMI group, (C) comparison of gender, (D) comparison of site. ABDN: Scotland, 
HUA: Greece, PYY: peptide YY. 
 
Figure 4. Plasma concentrations of ghrelin in the adult and elderly cohorts in response to all test 
drinks combined. Data are presented as mean ± SED, n = 172; seven ABDN participants (four normal 
weight adults, three normal weight elderly) did not complete this measurement. Determined using a 
human-specific radioimmunoassay kit, values were analyzed as repeated measurements using 
ANOVA, differences are statistically significant when p < 0.05. (A) Comparison of age group, (B) 
comparison of BMI group, (C) comparison of gender, (D) comparison of site. ABDN: Scotland, HUA: 
Greece. 
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Table 8 presents the gut hormones (GLP-1, PYY and ghrelin) drink type, composition and 
quantity x time interactions for all participants combined. There was a significant effect of drink type 
on concentrations of GLP-1 and PYY (both p < 0.001) and ghrelin (p < 0.005). The HP test drinks elicited 
a significantly greater increase in GLP-1 and PYY (both p < 0.001) in comparison to the NP drinks, 
however, protein content did not significantly affect ghrelin (p = 0.710). The MT test drinks elicited a 
significantly greater increase in GLP-1 and PYY (both p < 0.001) in comparison to the WL drinks (both 
p < 0.001), while ghrelin was suppressed to a significantly greater extent in response to the MT drinks 
compared to the WL drinks (p < 0.001). 
Pooled data from adults and elderly demonstrated that GLP-1 and PYY concentrations were 
negatively associated with ad libitum EI (both p < 0.001), while there was no significant association 
between ghrelin and ad libitum EI (p = 0.770). PYY concentrations were negatively associated with 
composite appetite score (p = 0.028), while the association between GLP-1 concentrations and 
composite appetite score approached significance (p = 0.052). There was no significant association 
between ghrelin concentrations and composite appetite score (p = 0.605). 
There were no significant differences in fasting leptin concentrations between adult and elderly 
participants (adults: 18.21 ng/mL; elderly: 20.86 ng/mL; p = 0.408; SED: 2.08). It is well established that 
obesity enhances the synthesis and release of leptin and, as anticipated, leptin concentrations were 
significantly higher in overweight participants compared to normal weight participants (overweight: 
29.49 ng/mL; normal weight: 10.26 ng/mL; p < 0.001; SED: 2.04). Females exhibited significantly 
greater concentrations of leptin than males (females: 26.55 ng/mL; males: 7.40 ng/mL; p < 0.001; SED: 
2.12). Leptin concentrations were also significantly greater in HUA participants compared to the 
ABDN cohort (HUA: 21.36 ng/mL; ABDN: 16.93 ng/mL; p = 0.016; SED: 1.98). The gender and site 
differences can be explained by differences in body composition. 
3.7.2. Glucose Homeostasis 
Table S7 presents the group x time interactions for glucose and insulin concentrations, and 
includes HOMA-IR, IGI and IGR. Elderly participants exhibited significantly greater concentrations 
of glucose (p < 0.001), insulin (P<0.001) and HOMA-IR (p < 0.001) compared to adults. As expected, 
glucose homeostasis was significantly influenced by BMI, with glucose (p < 0.001), insulin (p < 0.001), 
HOMA-IR (p < 0.001) and IGR (p = 0.006) greater in overweight compared to normal weight 
participants. Glucose (p = 0.036) and IGR (p = 0.005) were significantly greater in females compared 
to males. Glucose (p = 0.008), insulin (p = 0.005), HOMA-IR (p = 0.017) and IGR (p = 0.005) were 
significantly greater in the HUA cohort compared to the ABDN cohort. These significant group × 
time interactions were due to delayed insulin responses in elderly, overweight and HUA participants. 
Furthermore, differences in insulin concentrations between sites can be explained by differences in 
body composition. 
There were significant drink type (p < 0.001), composition (p < 0.05) and quantity (p < 0.001) × 
time interaction effects for glucose, insulin, HOMA-IR, IGI and IGR (Table S8). 
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Table 8. Combined adult and elderly1 appetite hormone concentrations at baseline and in response to test drink type, composition and quantity. 
Drink Time (min) GLP-1 (pg/mL) SED 
Drink.Time Interaction, p 
2 
PYY (pg/mL) SED 
Drink.Time Interaction, p 
2 








30 33.1 68.3 651 
60 26.6 69.6 596 
120 21.8 65.2 604 
NPMT 
0 11.9 43.5 762 
30 37.1 71.3 659 
60 31.3 74.3 584 
120 28.7 73.4 574 
HPWL 
0 12.1 44.9 767 
30 31.3 63.2 661 
60 27.6 63.4 603 
120 26.3 64.2 622 
HPMT 
0 12.5 45.2 763 
30 33.9 66.4 653 
60 31.1 67.3 578 








30 35.1 69.8 655 
60 29.0 72.0 590 
120 25.2 69.3 589 
HP 
0 12.3 45.1 765 
30 32.6 64.8 657 
60 29.4 65.4 591 







9 < 0.001 
30 32.2 65.7 656 
60 27.1 66.5 599 
120 24.1 64.7 613 
MT 
0 12.2 44.4 763 
30 35.5 68.8 656 
60 31.2 70.8 581 
120 28.7 69.9 573 
1 n = 172; seven ABDN participants (four normal weight adults, four normal weight elderly) did not complete this measurement; 2 determined by ANOVA, 
differences are statistically significant when p < 0.05. Mean data are presented for drink type (NPWL, NPMT, HPWL, HPMT), drink composition (NP, HP) and drink 
quantity (WL, MT); GLP-1: glucagon-like peptide 1, HP: high protein, HPMT: high-protein maintenance, HPWL: high-protein weight loss, MT: weight maintenance, 
NP: normal protein, NPMT: normal-protein maintenance, NPWL: normal-protein weight loss, PYY: pancreatic peptide YY, WL: weight loss.
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4. Discussion 
In relation to the primary aim of this study, the current novel findings demonstrate that ad 
libitum EI did not differ significantly between age groups, BMIs, genders or geographical locations, 
though composite appetite score was lower in the elderly subjects compared to the younger adults in 
response to drink type and quantity. The elderly group exhibited greater postprandial levels of GLP-
1 and PYY than the adult group, but ghrelin release was not affected by age. Concentrations of all 
appetite hormones were greater in females compared to males, while ghrelin levels were lower and 
fasting leptin levels were higher in overweight compared to normal weight participants. 
Furthermore, elevated ghrelin release and suppressed fasting leptin levels were observed in the 
ABDN cohort in comparison to the HUA cohort. As regards the secondary aim, ad libitum EI was 
not affected by drink composition, though concentrations of GLP-1 and PYY were higher in response 
to the HP compared to the NP test drinks. In addition, as might be expected, in response to the WL 
drink quantity, ad libitum EI was elevated, GLP-1 and PYY levels were lower and ghrelin 
concentrations were higher in comparison to the MT drink quantity. 
4.1. Ad Libitum EI and Subjective Appetite 
In the present study, there were no significant effects of the test meal on ad libitum EI between 
weight categories, gender, site or age; albeit we noted a trend towards differences between age 
groups in response to the quantity of drink provided below or at maintenance requirements. This 
approached significance, in part explained by the lower intakes in the elderly participants, which was 
also detected in their significantly lower subjective appetite score. Other authors have highlighted 
differences in appetite suppression between young and older healthy participants in response to 
protein and energy load [44], and this warrants further investigation to explore the influence of 
ageing on mechanisms of protein-induced satiety. Although we assessed subsequent ad libitum EI 2 
h after the breakfast drink, we did not measure 24 h EI, so it may be that energy compensation 
occurred later in the day. Belza et al. [25] also examined the effects of consuming an NP vs. HP test 
drink in adults. The HP drink led to reduced hunger and increased satiety compared to the NP drink. 
This might be because the HP drink that Belza et al. [25] used provided 50% energy from protein or 
88.4g protein per dose; there may be a threshold absolute concentration of protein required to 
stimulate protein-induced satiety, and the amount of protein supplied in our HP drink (10 g) may 
have fallen below this threshold. Furthermore, food form could be important for appetite control 
across the lifecourse. Indeed, Leidy et al. [23] demonstrated that a solid meal reduced lunch intake 
by approximately 480 kJ compared to a liquid meal in adolescents. By the nature of our current study 
design, we did not investigate the form of protein delivery and it is unclear as to whether a solid 
version would elicit greater changes. 
To the authors’ knowledge, this is one of the few studies to report the effects of study visit 
number on ad libitum EI. Interestingly, we observed that the children’s ad libitum EI was lower on 
the final visit compared to the first visit, in agreement with previous research [45], while the adult 
and elderly ad libitum EI was higher. Possible explanations for these findings may include children 
habituating to the buffet items following their initial, novel exposure to the buffet during visit 1, and 
the older age groups initially experiencing heightened feelings of anxiety before acclimatizing to the 
environment, as demonstrated previously [46]. Future studies may consider incorporating a 
familiarization/acclimatization session when assessing ad libitum EI, to reduce the effects of study 
visit order. 
4.2. Food Reward: LFPQ 
A greater liking and wanting for low-fat relative to high-fat foods and non-sweet relative to 
sweet foods was shown in the Greek participants. This difference may reflect in part the cultural 
norms for consuming sweet foods in the morning in Scotland but may also be due to the greater 
availability of fresh fruit and vegetables and the more traditional rather than “‘westernized” diet in 
Greece [47,48]. Indeed, a north–south European differentiation in food habits consistent with these 
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findings has previously been proposed [49]. We also found an age effect, with adults and the elderly 
having a greater liking and wanting for low-fat food compared to children and adolescents, and 
adults having a lower wanting of sweet foods compared to similarly high sweet wanting scores in 
children, adolescents and the elderly. Very few studies have examined food preferences across the 
lifecourse and, to our knowledge, no studies have examined both dimensions of fat and sweet taste 
in food. The findings on sweet taste preference are consistent with one psychophysical study showing 
that optimally preferred sucrose concentrations were higher for the elderly than for other age groups, 
except for the children [50]. As regards fat preferences, it is noted that the ability to accurately assess 
the fat content of foods is limited in humans, but adults may be more responsive to visual cues 
indicating the healthiness of food, which could influence food choice [51].  
4.3. Biomarkers 
GLP-1 is co-secreted with PYY by L cells in the lower intestine, with concentrations of both 
hormones increasing in response to a meal and inducing acute satiety [52–54]. Deficiencies in GLP-1 
and PYY have been reported in obese individuals [55–58], although not consistently [59–61] and not 
in the present study. We do, however, report higher postprandial concentrations of GLP-1 and PYY 
in the elderly and in females, which in the long term could partially facilitate weight reduction. 
Ageing modifies the gastrointestinal tract, causing alterations in gut hormone secretion and feedback 
mechanisms, which slow gastric emptying [62]. Furthermore, authors have observed slower gastric 
emptying rates in females compared to males [63,64]. Elevated concentrations of GLP-1 and PYY 
contribute to delayed gastric emptying and prolonged satiety [56,65]. Therefore, we speculate that 
slower gastric emptying in the elderly and female groups may have partially accounted for elevated 
postprandial levels of GLP-1 and PYY. In addition, gastric emptying and satiety hormones have been 
shown to fluctuate depending on the phase of the menstrual cycle [66–68], highlighting the important 
role of sex hormones in appetite control. 
Ghrelin is the only known gastrointestinal hormone to increase food intake [69]. Its 
concentrations peak prior to meal initiation and are suppressed by nutrient intake [69]. We report 
elevated fasting ghrelin concentrations in the normal weight compared to overweight participants 
and in females vs. males, as shown previously [70], however, postprandial patterns of response were 
similar. Ghrelin concentrations did not differ between adults and elderly, which agrees with previous 
data [71–75], though findings to the contrary have also been reported [76–79]. Ghrelin exists as two 
isoforms: acyl ghrelin, which stimulates energy intake [80,81] and des-acyl ghrelin, which may act 
independently from acyl ghrelin [82]. Most studies, including the present study, reporting no 
differences in ghrelin concentrations between younger and older adults [71–73,75], have measured 
total ghrelin (acyl and des-acyl ghrelin) only. However, studies measuring acyl ghrelin observe lower 
concentrations and an impaired postprandial response in the elderly [77–79]. Therefore, the form of 
ghrelin measured may contribute to discrepancies in the literature and merits further investigation. 
Although insulin is predominantly considered a principal regulator of glucose metabolism, it 
also acts on the arcuate nucleus of the hypothalamus to signal satiety [83]. Studies demonstrating 
increased satiety with age also report greater postprandial insulin concentrations in older compared 
to younger adults [73,78,84], in agreement with our findings. Insulin modulates changes in the 
circulation of leptin [85] and ghrelin [86] and may induce satiety indirectly by amplifying the 
anorectic actions of leptin and/or suppressing ghrelin secretion [86,87]. In the present study, we did 
not observe differences in leptin or ghrelin concentrations between adults and the elderly, suggesting 
that greater insulin secretion in the elderly was not sufficient to cause age-related differences in leptin 
and ghrelin release. 
This is one of the few studies to compare appetite control in different geographical locations. We 
observed lower ghrelin concentrations in HUA participants compared to those in ABDN. However, 
differences at baseline were accountable for postprandial differences between each “site”. 
Interestingly, we also observed elevated fasting leptin concentrations and postprandial insulin 
concentrations in the HUA cohort compared to the ABDN cohort, which may have partially 
modulated ghrelin expression. These are novel findings and not likely due to technical issues since 
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processing, storage and analysis were identical, instead, differences in leptin and insulin levels 
appear to be associated with differences in body composition between the two locations, though body 
composition did not account for differences in ghrelin concentrations and neither did gender. Future 
studies may consider the influence of geographical location on variations in appetite control, as other 
authors have suggested that differences are not related to habitual diet [88]. 
In the current study, we observed a significant decrease in ghrelin concentrations in response to 
the caloric load, but not the protein amount. This lack of protein-induced dose-dependent effect is 
reported by other authors [25,89]. It has been suggest that the postprandial decrease in ghrelin may 
be mediated through stimulation of gastric inhibitory polypeptide (GIP) and glucagon [25,90,91], 
possibly linked to gastric emptying, but also the carbohydrate content of the meal [25,91]. We also 
suggest that interactions between the protein and carbohydrate content is likely to influence ghrelin 
release, and that dietary carbohydrate may be a more potent stimulator than protein. Interestingly, 
in the current study, the HP drinks increased GLP-1 and PYY in comparison to the NP drinks. Belza 
et al. [25] provide a concise commentary on this aspect and suggest that these two hormones, in 
combination, do affect appetite after a protein-rich meal. 
4.4. Strengths and limitations 
The present study has several strengths, which include having a controlled diet intervention 
study conducted as a randomized crossover design in a large cohort taking account of age, body size, 
gender and geographical location. For some factors (such as drink), this study has the strengths of a 
crossover design, whereas for others (such as age), there are the unavoidable limitations of studying 
observable factors. As with any lab-based dietary intervention study, there are limitations, such as 
limited ecological validity, the amount and type of protein and many phenotypic effects which have 
not been investigated. The iso-energetic load for the meals was achieved by reducing carbohydrate 
content, so we cannot rule out the effect of this lower carbohydrate nutrient profile of the high-protein 
meal to contribute to the study results. We presented unadjusted p-values for comparing treatment 
groups in tests of several variables, to preserve the power of the study, so although there are clear 
patterns of significant differences, there is a risk that a small proportion of these are type I errors. 
Therefore, significant p-values presented within the present study come with this caveat, which 
should be considered when interpreting our findings. We recruited people motivated to respond to 
a diet trial and, consequently, this is not a truly random sample. Furthermore, had we recruited a 
much larger sample size, this may have allowed the statistical results to be generalized to a larger 
population or phenotype. Finally, long-term intervention and monitoring across the lifecourse to 
assess the mechanisms underlying changes in appetite control were out with the scope of this study. 
5. Conclusions 
The primary aim of this study was to describe the acute regulation of appetite across the 
lifecourse, thus being able to detect differences between four different age groups (children, 
adolescents, adult and elderly), two different weight categories (normal weight and overweight), the 
two genders (male and female) and two European sites (Aberdeen, Scotland and Athens, Greece). 
The present study shows that the elderly reported lower subjective appetite ratings in response to the 
different drink types and quantities in comparison to the adults. Furthermore, in agreement with Di 
Francesco et al. [73], postprandial anorexigenic signals prevailed over orexigenic signals in the 
elderly, which over time could induce an energy deficit and accentuate the anorexia of ageing. In 
addition to age, differences in appetite hormone concentrations between BMIs, genders and 
geographical locations were also observed, the latter of which being of particular interest, as location 
is rarely considered in the context of acute appetite control. Future research may consider expanding 
upon our findings and examining the role of appetitive neuronal circuits in food–gut–brain 
interactions across the lifecourse. 
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